Rachel Day is an Associate Director of Clinical Science at Nuvalent, Inc., with a rich background in oncology-focused drug development spanning over 15 years. Previously, Rachel served as a Senior Scientist at Precision For Medicine, where they honed their expertise in clinical data review and vendor management for immuno-oncology initiatives. Earlier in their career, Rachel held multiple leadership roles at the Sarah Cannon Research Institute, including Senior Manager of Clinical Operations, and worked as a Staff Nurse at Ascension. Rachel earned their degree from Middle Tennessee State University between 2000 and 2006 and is dedicated to empowering clinical advancement and improving patient outcomes through innovative therapies.
This person is not in any teams
This person is not in any offices